This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- Sumi Dinda, PhD⇑
- Address for Correspondence: Sumi Dinda, PhD, School of Health Science, Biomedical Diagnostic & Therapeutic Sciences, 356 HH, Oakland University Rochester, MI 48309. 248-370-2456. sdinda{at}oakland.edu
Define the roles of estrogen and progesterone in breast and uterine cells.
Define hormone-dependent and independent tumors.
Describe the classification and main functions of anti-hormone therapy.
Explain the mechanism of aromatase inhibitors, ERDs and SERMs.
Explain the differences between the mechanisms of tamoxifen and raloxifene.
Abstract
Breast cancer is the second-leading cause of cancer-related death in women. Recently, new drugs are being developed based on the molecular mechanisms of receptors, tumor suppressor genes, monoclonal antibodies, tumor markers and anti-hormone therapy. Anti-hormone therapy is used in the treatment of hormone-dependent breast tumors. Among the anti-hormone therapies, a substantial amount of research has been focused on the development of the ideal selective estrogen receptor modulator to treat metastatic breast tumors and to prevent breast cancer in high risk women.
- © Copyright 2012 American Society for Clinical Laboratory Science Inc. All rights reserved.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.